Drug Approval | May 27, 2023
Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
The product is expected to be launched in June 2023
The product is expected to be launched in June 2023
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
Marksans' OTC Famotidine Tablets USP are acid reducers
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Subscribe To Our Newsletter & Stay Updated
